Navigation Links
International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining
Date:10/1/2009

The 2nd DIA Conference on Signal Detection and Data Mining will be held from November 16-18, 2009 in New York, NY. This three-day conference will explore address all aspects of signal detection and data mining, including methodologies, clinical interpretation, and international harmonization initiatives.

Horsham, PA (PRWEB) October 1, 2009 -- The 2nd DIA Conference on Signal Detection and Data Mining will be held from November 16-18, 2009 in New York, NY. This three-day conference will explore address all aspects of signal detection and data mining, including methodologies, clinical interpretation, and international harmonization initiatives.

Experts will discuss:

 
  • Future for analysis of spontaneous reports and other healthcare data with potential applicability to pharmacovigilance
  • Signal detection successes resulting from data mining spontaneous reports, with a discussion of the pitfalls, evaluation and validation of the methods and real-world implementation
  • Update on the networks of pharmacoepidemiology and the use of longitudinal/observational databases for signal detection purposes
  • Update on CIOMS VIII working group on signal detection and management
  • FDA Sentinel Initiative and the Observational Medical Outcomes Partnership (OMOP)

"The use of data mining methods to screen collections of Individual Case Safety Reports for important reporting patterns has gone from proof-of-concept to widespread use," says Program Committee Member Andrew Bate, PhD, Director, Quantitative Epidemiology, Pfizer Inc. "Currently, there is a growing interest in screening other sources of real-world medical information for emerging safety issues and developing computational methods which do not rely on disproportionality analysis. This conference will bring together an international group of experts to review current state-of-the-art thinking on the future developments in data mining and signal detection and a vision of how public health and patient safety issues will be detected faster and more effectively in the future."

Click here to register.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact: Joe Krasowski
DIA
+1-215-293-5812

# # #

Read the full story at http://www.prweb.com/releases/DIA_conference/signal_detection/prweb2978214.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity
2. Temps Inc. Acquires Medical Concepts Staffing Business From Analysts International Corporation
3. Director of UT Southwestern center honored with first international neurology medal
4. Hong Kong International Media Conference 2010
5. Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
6. McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan
7. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
8. Yanda International Health City - World Class Healthcare in China
9. Osseon Signs International Distribution Agreement With MBA Incorporado
10. Cohera Medical Receives ISO 13485 Certification: Company Meets International Standards for Design, Development and Manufacturing of Medical Devices
11. CEO and Founder of Project Lifesaver International, Gene Saunders, Selected to Receive Two Awards From Local Community
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 
(Date:12/10/2016)... ... 10, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... other healthcare organizations to promote diabetes education at the World Diabetes Day observance. ... of speakers from around the Commonwealth of Pennsylvania. Speakers included Dr. Renu ...
(Date:12/9/2016)... ... December 09, 2016 , ... The American ... audiologists—to remain a critical part of public access to hearing aid technology. , ... announced this week that, starting immediately, it would no longer enforce the ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... folded, pharmaceutical inserts and outserts. As a means of expanding capabilities Flottman ... will enable Flottman to individually code professional inserts (PIs) and patient package inserts ...
(Date:12/9/2016)... Woodland Hills, CA (PRWEB) , ... December 09, ... ... center for young adults, celebrated its 10th anniversary with the grand opening of ... Hills, California. The successful event spanned two days, December 2-3, and was attended ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Hotel in New York, NY, on December 3rd, to benefit Holy Name Medical ... the annual event, which raised over $1 million - the largest event in ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... grow in 2017-2023. Various reasons for growth of the ... higher incidences of chronic diseases, high recovery cost of ... services. Medical lifting sling refers to an assistive ... mobility. These slings connect to the lift and hold ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
Breaking Medicine Technology: